GLL 398 is a potent and selective oral estrogen receptor degrader, demonstrating an IC50 of 1.14 nM. It effectively inhibits tumor growth in breast cancer xenograft models, supporting its use in both in vitro mechanistic studies and in vivo preclinical research for hormone receptor-positive cancers.
Molekulargewicht:
398.26
CAS Nummer:
[2077980-80-2]
Formel:
C25H23BO4
Target-Kategorie:
Estrogen Receptor/ERR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten